These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2111589)

  • 1. Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity.
    Chandler WL; Mornin D; Whitten RO; Angleton P; Farin FM; Fritsche TR; Veith RC; Stratton JR
    Thromb Res; 1990 Apr; 58(1):1-12. PubMed ID: 2111589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M; Miyashita C
    Klin Wochenschr; 1988; 66 Suppl 12():62-7. PubMed ID: 3126347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).
    Angleton P; Chandler WL; Schmer G
    Circulation; 1989 Jan; 79(1):101-6. PubMed ID: 2491971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinetic model of the circulatory regulation of tissue plasminogen activator.
    Chandler WL
    Thromb Haemost; 1991 Sep; 66(3):321-8. PubMed ID: 1746003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variation of fibrinolytic activity in blood.
    Andreotti F; Kluft C
    Chronobiol Int; 1991; 8(5):336-51. PubMed ID: 1818784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
    Falkon L; Garí M; Borrell M; Fontcuberta J
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina.
    Sakata K; Hoshino T; Yoshida H; Ono N; Ohtani S; Yokoyama S; Mori N; Kaburagi T; Kurata C; Urano T
    Am Heart J; 1992 Oct; 124(4):854-60. PubMed ID: 1529901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levels.
    Juhan-Vague I; Alessi MC; Raccah D; Aillaud MF; Billerey M; Ansaldi J; Philip-Joet C; Vague P
    Thromb Haemost; 1992 Jan; 67(1):76-82. PubMed ID: 1615488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture.
    Pandolfi A; Iacoviello L; Capani F; Vitacolonna E; Donati MB; Consoli A
    Diabetologia; 1996 Dec; 39(12):1425-31. PubMed ID: 8960822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Change in the Sleep/Wake Cycle on the Diurnal Variation of Fibrinolytic Parameters.
    Irokawa M; Nishinaga M; Funayama H; Ikeda U; Shimada K
    J Thromb Thrombolysis; 1998 May; 5(2):165-168. PubMed ID: 10767112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic response during exercise and epinephrine infusion in the same subjects.
    Chandler WL; Veith RC; Fellingham GW; Levy WC; Schwartz RS; Cerqueira MD; Kahn SE; Larson VG; Cain KC; Beard JC
    J Am Coll Cardiol; 1992 Jun; 19(7):1412-20. PubMed ID: 1593033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.
    Takada A; Takada Y; Urano T; Sakakibara K; Rydzewski A
    Thromb Res; 1990 Jan; 57(1):13-20. PubMed ID: 2105539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C; Jie AF; Rijken DC; Verheijen JH
    Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endurance training on the circadian rhythm of fibrinolysis in men and women.
    Chandler WL; Schwartz RS; Stratton JR; Vitiello MV
    Med Sci Sports Exerc; 1996 Jun; 28(6):647-55. PubMed ID: 8784750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis.
    Marckmann P; Sandström B; Jespersen J
    Atherosclerosis; 1993 Jul; 101(2):225-34. PubMed ID: 8397516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian variation in fibrinolytic activity in patients with variant angina.
    Masuda T; Ogawa H; Miyao Y; Yu Q; Misumi I; Sakamoto T; Okubo H; Okumura K; Yasue H
    Br Heart J; 1994 Feb; 71(2):156-61. PubMed ID: 8130024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.